Society ❯ Health Issues ❯ Obesity

Treatment Options

Patient Access Patient Experiences GLP-1 Drugs Lifestyle Medications Economic Impact Pharmaceutical Innovations Medication Access Injections for Weight Loss Access to Medications Wegovy

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

The upgrade positions the site to supply markets outside the U.S. ahead of a possible EMA decision on the Wegovy pill.

Eli Lilly Unveils $3 Billion Netherlands Plant to Scale Production of Oral Weight‑Loss Pill